Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology

NCT ID: NCT06753045

Last Updated: 2025-01-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-08

Study Completion Date

2027-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a phase 0, non-interventional, longitudinal, electronic data capture (EDC) study to facilitate the HEARTBEAT Study project has set out to explore the potential use of smartwatches in collecting and analyzing biometric data to improve the detection, identification, and understanding of cardiovascular diseases and related conditions by SAMSUNG and Tulane. The study will include up to ten thousand adult subjects tasked with wearing a smartwatch to collect digital biomarker data over a 1 year period. Concurrent to smartwatch data collection, subjects will be instructed to complete questionnaires via the Huma Decentralized Clinical Trials (HUMADCT) platform. There are no investigational drugs or interventions administered as part of this study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The central hypothesis in the HEARTBEAT project posits that cardiovascular events are preceded by abnormalities in biometric signals obtained from a smartwatch. These abnormalities may include, but are not limited to, patterns of heart rate, heart rate variability, oxygen saturation, as well as raw PPG signals. By leveraging advanced analytics and machine learning algorithms on smartwatch-derived biometric data, the investigators plan to identify patterns and markers that signal an increased cardiovascular disease risk.

The study will use an end-to-end decentralized approach for data collection. Huma and Alcedis, the electronic data capture (EDC) agencies, will act as the data storage facilitator for 10,000 eligible subjects. The Principal Investigators (PIs) and trained site staff members will assess healthy subjects based on their clinical opinion. If the subjects meet the eligibility criteria and are interested in participating, they will be consented by Tulane.

During the study enrollment phase, a smartwatch will be provided to the subjects, who will then be trained on the study procedures, the web-based questionnaire, and the use of the wearable device. The subjects will be asked to wear the device for one year, after which they will return it to Tulane.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cohort arm

Patients with at least one cardiovascular disease, 9500 subjects.

Smartwatch

Intervention Type OTHER

Sensors on the smartwatch will measure vitals such as heart rate, blood pressure, oxygen saturation, body composition, and electrocardio gram (ECG)

Healthy arm

Patients visiting a primary care provider for any reason without any cardiovascular diseases, 500 subjects.

Smartwatch

Intervention Type OTHER

Sensors on the smartwatch will measure vitals such as heart rate, blood pressure, oxygen saturation, body composition, and electrocardio gram (ECG)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Smartwatch

Sensors on the smartwatch will measure vitals such as heart rate, blood pressure, oxygen saturation, body composition, and electrocardio gram (ECG)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with at least one cardiovascular disease (heart failure, cardiac arrhythmias, chronic kidney disease, coronary artery disease, history of stroke/Transient Ischemic Attack (TIA), or diabetes mellitus).
* Patients visiting a primary care provider for any reason without any of the previously mentioned cardiovascular diseases. (Healthy cohort, limited up to 500 patients throughout the study).

Exclusion Criteria

* Participants who cannot read, speak, and/or understand English.
* Participants with cognitive impairments who are unable to give informed consent or sign their HIPAA form.
* Participants with cognitive impairments affecting their ability to be compliant with wearing and maintaining wearable devices.
* Participants who are pregnant.
* Participants with tattoos, scars, or skin adhesions that would not allow for Photoplethysmography (PPG) recordings to be collected from a wrist-worn device.
* Participants with neurological disorders that may interfere with device signal quality (e.g., hand tremors).
* Participants with a pacemaker.
* Participants with allergies to watch and/or wristband materials.
* Participants with known plans to permanently leave the state of Louisiana within the observational period.
* Participants who have no known medical history with any of the enrolling institutions.
* Patients without a compatible smartphone (iOS 13 \& Android 11 at minimum).
Minimum Eligible Age

18 Years

Maximum Eligible Age

120 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Samsung Electronics

INDUSTRY

Sponsor Role collaborator

Tulane University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nassir Marrouche, MD

Role: PRINCIPAL_INVESTIGATOR

Tulane University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

East Jefferson General Hospital

New Orleans, Louisiana, United States

Site Status RECRUITING

Tulane University Medical Group Clinics

New Orleans, Louisiana, United States

Site Status RECRUITING

University Medical Center

New Orleans, Louisiana, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kunal Sameer, MD

Role: CONTACT

504-988-3058

Quintrele Jones, MPH

Role: CONTACT

504-988-3063

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kunal Sameer, MD

Role: primary

504-988-3058

Quintrele Jones, MPH

Role: backup

504-988-3063

Kunal Sameer, MD

Role: primary

504-988-3058

Quintrele Jones, MPH

Role: backup

504-988-3063

Kunal Sameer, MD

Role: primary

504-988-3058

Quintrele Jones, MPH

Role: backup

504-988-3063

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-652

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Withings ECG-app Study
NCT05316350 COMPLETED NA
Withings ECG-Monitor Study
NCT05316337 COMPLETED NA
Health App Data Collection Study
NCT06595615 NOT_YET_RECRUITING